Search hospitals > Florida > Lake Worth
JEM Research Institute
Claim this profileLake Worth, Florida 33462
Global Leader in Alzheimer's Disease
Global Leader in Dementia
Conducts research for Parkinson's Disease
Conducts research for Cognitive Impairment
Conducts research for Mild Cognitive Impairment
92 reported clinical trials
2 medical researchers
Summary
JEM Research Institute is a medical facility located in Lake Worth, Florida. This center is recognized for care of Alzheimer's Disease, Dementia, Parkinson's Disease, Cognitive Impairment, Mild Cognitive Impairment and other specialties. JEM Research Institute is involved with conducting 92 clinical trials across 63 conditions. There are 2 research doctors associated with this hospital, such as Mark Goldstein, MD and Linda Pao, MD.Area of expertise
1Alzheimer's Disease
Global LeaderAβ1-42 positive
APOE4 positive
APOE4 negative
2Dementia
Global LeaderTop PIs
Mark Goldstein, MDJEM Research Institute4 years of reported clinical research
Expert in Alzheimer's Disease
Studies Colorectal Cancer
28 reported clinical trials
45 drugs studied
Linda Pao, MDJEM Research Institute2 years of reported clinical research
Studies Dementia
Studies Lewy Body Disease
2 reported clinical trials
2 drugs studied
Clinical Trials running at JEM Research Institute
Alzheimer's Disease
Dementia
Mild Cognitive Impairment
Multiple Sclerosis
Alzheimer's Dementia
Cognitive Impairment
Parkinson's Disease
Obesity
Diabetes
Chronic Kidney Disease
AVP-786
for Agitation in Alzheimer's Disease
This trial is testing a medication called AVP-786 on individuals who have taken part in previous studies. The goal is to see if this medication can help with their conditions over time.
Recruiting2 awards Phase 37 criteria
Aducanumab
for Alzheimer's Disease
The primary objective of this study is to verify the clinical benefit of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by changes in the Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) score as compared with placebo in participants with early Alzheimer's disease.
Recruiting1 award Phase 31 criteria
Donanemab
for Alzheimer's Disease
This trial is testing donanemab, a medication aimed at helping people with Alzheimer's Disease by removing harmful protein clumps from their brains. Donanemab has shown promise in reducing these harmful proteins in Alzheimer's disease.
Recruiting1 award Phase 34 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at JEM Research Institute?
JEM Research Institute is a medical facility located in Lake Worth, Florida. This center is recognized for care of Alzheimer's Disease, Dementia, Parkinson's Disease, Cognitive Impairment, Mild Cognitive Impairment and other specialties. JEM Research Institute is involved with conducting 92 clinical trials across 63 conditions. There are 2 research doctors associated with this hospital, such as Mark Goldstein, MD and Linda Pao, MD.